• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS ESHEATH PLUS; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS ESHEATH PLUS; INTRODUCER, CATHETER Back to Search Results
Model Number 914ESPA
Device Problem Material Integrity Problem (2978)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/08/2022
Event Type  malfunction  
Manufacturer Narrative
Investigation is ongoing.
 
Event Description
As reported by field clinical specialist, a patient successfully underwent a transfemoral tavr procedure with a 23mm s3 ultra valve in the aortic position.During removal of the esheath, the physician noticed the sheath was "damaged/frayed" horizontally at the distal tip at the radiopaque marker.There was no difficulty noted inserting the sheath into the patient and no difficulties noted inserting the delivery system through the sheath.The physician did not experience any withdrawal difficulty.There was no abnormalities noted along the liner and/or shaft after removing the esheath from packaging or during prep.There was no harm to the patient.Surgical cutdown was the initial primary access.Dilator was not used during sheath removal.
 
Manufacturer Narrative
A supplemental mdr is being submitted due to engineering evaluation findings.Sections b4, d9, g3, g6, h2, h3, h6: type of investigation, investigation findings, investigation conclusions and h10 has been updated.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of this event is not required at this time.The complaint for sheath distal tip torn was confirmed per evaluation of the returned device.However, no manufacturing nonconformance was identified during evaluation.Review of the dhr and lot history did not provide any indication that a manufacturing non-conformance would have contributed to the complaints.A review of manufacturing mitigations supports that the sheath has proper inspections in place to detect issues related to the complaint events.A review of ifu/training materials revealed no deficiencies.Furthermore, no abnormalities were noted during device unpacking or preparation.Per the complaint description, -during removal of the esheath, the physician noticed the sheath was "damaged/frayed" horizontally at the distal tip at the radiopaque marker.There was no difficulty noted inserting the sheath into the patient and no difficulties noted inserting the delivery system through the sheath.The physician did not experience any withdrawal difficulty.There was no abnormalities noted along the liner and/or shaft after removing the esheath from packaging or during prep.- per evaluation of the returned device, the sheath distal tip was observed to be torn radially along the distal edge of the liner.The failure mode is characteristic of sheath tip tear events.While a definitive root cause was unable to be determined, previous investigation indicated that the tear is attributed to improper tip expansion, resulting in interference between the valve and sheath tip.As such, it is possible that improper tip expansion contributed to the experienced delivery system advancement resistance at the sheath distal tip and the distal tip tear.Additionally, 3mensio imagery was also provided and shows the presence of access vessel tortuosity near the aortic bifurcation.Per the training manual, -push force can vary due to angle of access and insertion, thv size, vessel diameter, tortuosity and degree of calcification-.Tortuosity can lead to non-coaxial alignment between the crimped valve and the sheath, which may lead the valve struts to catch onto the sheath distal tip, tearing the tip.As such, the failure mode may be related to improper expansion of the sheath tip during thv advancement and/or patient factors (tortuosity) may have contributed to the complaint events.However, a definitive root cause was unable to be determined at this time.The ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS ESHEATH PLUS
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key15154548
MDR Text Key301943185
Report Number2015691-2022-07121
Device Sequence Number1
Product Code DYB
UDI-Device Identifier00690103215465
UDI-Public(01)00690103215465(17)240315(11)2203162164278155
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K200258
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/15/2024
Device Model Number914ESPA
Device Catalogue Number914ESPA
Device Lot Number64278155
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/08/2022
Initial Date FDA Received08/03/2022
Supplement Dates Manufacturer Received10/15/2022
Supplement Dates FDA Received10/19/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age77 YR
Patient SexFemale
-
-